545 related articles for article (PubMed ID: 21664889)
1. Atypical fibroxanthoma and malignant fibrous histiocytoma.
Withers AH; Brougham ND; Barber RM; Tan ST
J Plast Reconstr Aesthet Surg; 2011 Nov; 64(11):e273-8. PubMed ID: 21664889
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
3. Recurrent Atypical Fibroxanthoma Versus Malignant Fibrous Histiocytoma.
Branch LG; Albertini JG; Leshin B
J Craniofac Surg; 2015 Jun; 26(4):e322-3. PubMed ID: 26080249
[TBL] [Abstract][Full Text] [Related]
4. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
Ly H; Selva D; James CL; Huilgol SC
Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
[TBL] [Abstract][Full Text] [Related]
5. CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker.
Hartel PH; Jackson J; Ducatman BS; Zhang P
J Cutan Pathol; 2006 Sep; 33 Suppl 2():24-8. PubMed ID: 16972949
[TBL] [Abstract][Full Text] [Related]
6. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2001 Nov; 32(11):1225-31. PubMed ID: 11727262
[TBL] [Abstract][Full Text] [Related]
7. Atypical fibroxanthoma with perineural or intraneural invasion: report of two cases.
Dettrick A; Strutton G
J Cutan Pathol; 2006 Apr; 33(4):318-22. PubMed ID: 16630185
[TBL] [Abstract][Full Text] [Related]
8. Fine-needle aspiration cytopathology of malignant fibrous histiocytoma.
Berardo MD; Powers CN; Wakely PE; Almeida MO; Frable WJ
Cancer; 1997 Aug; 81(4):228-37. PubMed ID: 9292738
[TBL] [Abstract][Full Text] [Related]
9. Atypical fibroxanthoma-a diagnosis of exclusion!
Tchernev G; Tronnier M; Ananiev J; Taneva T; Patterson JW; Gulubova M; Trafeli JP; Gegova A; Harrell M; Guarneri C; Wollina U; Cardoso JC; Kanazawa N; Zisova L; Forsea AM; Zouboulis CC
Wien Med Wochenschr; 2013 Aug; 163(15-16):380-6. PubMed ID: 23319144
[TBL] [Abstract][Full Text] [Related]
10. Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining.
Oshiro Y; Fukuda T; Tsuneyoshi M
Cancer; 1995 Mar; 75(5):1128-34. PubMed ID: 7850711
[TBL] [Abstract][Full Text] [Related]
11. Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children's Research Hospital experience.
Daw NC; Billups CA; Pappo AS; Jenkins JJ; Mahmoud HH; Krasin MJ; Rao BN
Cancer; 2003 Jun; 97(11):2839-47. PubMed ID: 12767098
[TBL] [Abstract][Full Text] [Related]
12. Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: a collective experience.
McCoppin HH; Christiansen D; Stasko T; Washington C; Martinez JC; Brown MD; Zwald FO
Dermatol Surg; 2012 Feb; 38(2):230-9. PubMed ID: 22129349
[TBL] [Abstract][Full Text] [Related]
13. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
Rizzardi C; Angiero F; Melato M
Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
[TBL] [Abstract][Full Text] [Related]
14. [Metastasizing soft tissue tumor of light damaged skin: atypical fibroxanthoma or malignant fibrous histiocytoma?].
Beck HG; Lechner W; Wünsch PH
Z Hautkr; 1985 Nov; 60(21):1702-4, 1707-10, 1713. PubMed ID: 3000095
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma.
Westermann FN; Langlois NE; Simpson JG
Am J Dermatopathol; 1997 Jun; 19(3):228-31. PubMed ID: 9185907
[TBL] [Abstract][Full Text] [Related]
16. Atypical fibroxanthoma: clinicopathologic determinants for recurrence and implications for surgical management.
Davidson JS; Demsey D
J Surg Oncol; 2012 May; 105(6):559-62. PubMed ID: 22025342
[TBL] [Abstract][Full Text] [Related]
17. [Atypical fibroxanthoma and pleomorphic dermal sarcoma].
Ziemer M; Jäger IM; Dippel E
Hautarzt; 2019 Sep; 70(9):661-669. PubMed ID: 31468069
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous malignant fibrous histiocytoma: a case report.
Bose AC; Kate V; Ananthakrishnan N; Srinivasan S
Med Sci Monit; 2006 Jul; 12(7):CS61-3. PubMed ID: 16810139
[TBL] [Abstract][Full Text] [Related]
19. [Malignant fibrous histiocytoma. Case report].
Morlino A; Rossi MT; Fabrizio T; Scutari F
G Chir; 2010 Mar; 31(3):91-5. PubMed ID: 20426919
[TBL] [Abstract][Full Text] [Related]
20. [Current topics in the diagnosis and treatment of malignant fibrous histiocytoma].
Chuman H
Gan To Kagaku Ryoho; 2003 May; 30(5):626-33. PubMed ID: 12795093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
